Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

The FDA announcement confirms that the U.S. supply of both prescription-only drugs now meets or exceeds the current and ...

Wegovy. Zepbound… and yes, Ozempic. A Kaiser Family Foundation poll found that one in 8 American adults reported trying a GLP-1 medication. “Body by Ozempic” has become a punchline on red ...

One in eight adults in the U.S. has taken Ozempic or another type of GLP-1 drug, surveys show — and now a major new study has revealed a long list of benefits and some little-known risks.

The Food and Drug Administration approved Ozempic for treating patients with ... with diabetes have chronic kidney disease. Both type 1 and type 2 diabetes can cause kidney disease, the agency ...

as well as cardiovascular and kidney death with a 1 mg/kg weekly dose of the injectable drug compared to placebo. That is the same dose of the drug used in the formulation of Ozempic used for the ...